Skip to main content

Overview of Gynecologic Oncology Fellowship Program

The Duke fellowship is a three-year program. The first year is devoted entirely to research and there are NO clinical responsibilities. This allows the fellows to focus all of their efforts on the research projects they have chosen. One year of research has provided an excellent introductory exposure and allows the fellows to achieve authorship on multiple papers and complete their thesis. Graduate level courses are also part of the research year, including biostatistics and an introduction to clinical research. Some fellows have worked on ovarian and endometrial cancer molecular biology projects in the lab. In the past few years most have undertaken clinical, health services and cost effectiveness projects. Duke has an outstanding Masters Program in Clinical Research (http://crtp.mc.duke.edu/index.htm) that some fellows have completed. 

The second and third years of the fellowship are spent almost entirely on the Gynecologic Oncology service at Duke University Medical Center. Most of the clinical activities are conducted in the new state of the art Duke Cancer Institute outpatient clinic and in the adjacent inpatient hospital. The fellowship program features a balanced mix between open, laparoscopic and robotic surgery, and we have widely adopted sentinel lymph node mapping approaches. We also manage chemotherapy treatment of our patients, including new biological targeted therapies. The fellowship includes significant experience in palliative care, as we follow our patients throughout the course of their journey. We also benefit from extensive interactions with Palliative Care specialists at Duke. Our division is also the focal point for evaluation, genetic testing and management of hereditary gynecologic cancers.  We are leading contributors to NRG Oncology, GOG Foundation, and industry clinical trials. The senior fellow spends time on the Radiation Oncology service and has the option of spending one month on the GI or GU surgery service at Duke. 

Upon completion of the Duke Gynecologic Oncology fellowship, trainees as well prepared for a career in this challenging and rewarding subspecialty.

Gynecologic Oncology Faculty

Andrew Berchuck, MD, Professor and Director
Research interest in molecular pathogenesis of ovarian cancer

Angeles Alvarez-Secord, MD MHSc, Professor
Director of Gynecologic Oncology Clinical Trials
Research interest in novel therapeutics, biomarkers, tumor microenvironment, and obesity

Laura Havrilesky, MD MHSc, Professor
Director of Health Services research

Paula Lee, MD, Assistant Professor
Director, Gynecologic Oncology fellowship
Palliative care and global health

Brittany Davidson, MD, Assistant Professor
Palliative care and resident education

Rebecca Previs, MD, Assistant Professor
Cell signaling mechanisms in ovarian cancer

Gynecologic Oncology Fellows

Jonathan Foote, MD - Third Year (Residency, Medical University of South Carolina)
Haley Moss, MD – Second Year (Residency, New York University)
Allison Puechl, MD – First Year (Residency, Duke Medical Center)

Other Gynecologic Oncology
Team Members

Susan Murphy, PhD, Associate Professor
Epigenetics and stem cell biology

Noah Kauff, MD, Associate Professor
Director, Duke Clinical Cancer Genetics program